A228850 Stock Overview
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rayence Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩8,420.00 |
| 52 Week High | ₩12,450.00 |
| 52 Week Low | ₩8,030.00 |
| Beta | 1.04 |
| 1 Month Change | -6.65% |
| 3 Month Change | -7.27% |
| 1 Year Change | -29.89% |
| 3 Year Change | -37.16% |
| 5 Year Change | -49.12% |
| Change since IPO | -63.47% |
Recent News & Updates
Recent updates
We Think Rayence (KOSDAQ:228850) Can Stay On Top Of Its Debt
Mar 31
Rayence Co., Ltd. (KOSDAQ:228850) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?
Mar 05Will Rayence (KOSDAQ:228850) Multiply In Value Going Forward?
Feb 17Are Rayence's (KOSDAQ:228850) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Feb 02Rayence's(KOSDAQ:228850) Share Price Is Down 44% Over The Past Three Years.
Jan 18Should Rayence Co., Ltd. (KOSDAQ:228850) Be Part Of Your Dividend Portfolio?
Jan 06Income Investors Should Know That Rayence Co., Ltd. (KOSDAQ:228850) Goes Ex-Dividend Soon
Dec 25At ₩11,100, Is It Time To Put Rayence Co., Ltd. (KOSDAQ:228850) On Your Watch List?
Dec 14
Rayence (KOSDAQ:228850) Seems To Use Debt Quite Sensibly
Dec 01A Look At The Intrinsic Value Of Rayence Co., Ltd. (KOSDAQ:228850)
Nov 18Shareholder Returns
| A228850 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -2.3% | -0.1% | -4.3% |
| 1Y | -29.9% | 18.0% | -1.0% |
Return vs Industry: A228850 underperformed the KR Medical Equipment industry which returned 18% over the past year.
Return vs Market: A228850 underperformed the KR Market which returned -1% over the past year.
Price Volatility
| A228850 volatility | |
|---|---|
| A228850 Average Weekly Movement | 1.4% |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A228850 has not had significant price volatility in the past 3 months.
Volatility Over Time: A228850's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2011 | 222 | Jae-jeong Seo | www.rayence.com |
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-Si TFT X-ray detectors for applications, such as dental, veterinary, AXI, die-casting, 2D/3D inline/offline, pipe inspection, etc. It also provides radiography imaging software products, including Xmaru Pro, Xmaru View V1, Xmaru W, Xmaru RF, Xmaru NDT, Vetview Pro, VXV console, Ez Dent Vet, Xmaru PACS, and VXV PACS; medical information systems for veterinary hospitals; and engages in veterinary medical device and drug wholesale and retail business, as well as research and development of process facilities and deposition materials. The company was founded in 2011 and is headquartered in Hwaseong-si, South Korea.
Rayence Co., Ltd. Fundamentals Summary
| A228850 fundamental statistics | |
|---|---|
| Market cap | ₩132.50b |
| Earnings (TTM) | ₩19.60b |
| Revenue (TTM) | ₩142.99b |
6.8x
P/E Ratio0.9x
P/S RatioIs A228850 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A228850 income statement (TTM) | |
|---|---|
| Revenue | ₩142.99b |
| Cost of Revenue | ₩85.09b |
| Gross Profit | ₩57.89b |
| Other Expenses | ₩38.29b |
| Earnings | ₩19.60b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.25k |
| Gross Margin | 40.49% |
| Net Profit Margin | 13.71% |
| Debt/Equity Ratio | 0.9% |
How did A228850 perform over the long term?
See historical performance and comparison